| Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment U Vogel, MK Taha, JA Vazquez, J Findlow, H Claus, P Stefanelli, ... The Lancet infectious diseases 13 (5), 416-425, 2013 | 348 | 2013 |
| Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 LS S. S. Ahmed, W. Volkmuth, J. Duca, L. Corti, M. Pallaoro, A. Pezzicoli, A ... Science Translational Medicine 7 (294), 294, 2015 | 282 | 2015 |
| Gene expression phenotypes of atherosclerosis D Seo, T Wang, H Dressman, EE Herderick, ES Iversen, C Dong, K Vata, ... Arteriosclerosis, thrombosis, and vascular biology 24 (10), 1922-1927, 2004 | 176 | 2004 |
| Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage G Frosi, A Biolchi, ML Sapio, F Rigat, S Gilchrist, J Lucidarme, J Findlow, ... Vaccine 31 (43), 4968-4974, 2013 | 157 | 2013 |
| Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined M Biagini, M Spinsanti, G De Angelis, S Tomei, I Ferlenghi, M Scarselli, ... Proceedings of the National Academy of Sciences 113 (10), 2714-2719, 2016 | 75 | 2016 |
| Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia DZH Levett, DS Martin, MH Wilson, K Mitchell, S Dhillon, F Rigat, ... BMC medical research methodology 10, 1-14, 2010 | 71 | 2010 |
| The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular … M Fabbrini, F Rigat, CD Rinaudo, I Passalaqua, S Khacheh, R Creti, ... Clinical Infectious Diseases 63 (6), 746-753, 2016 | 63 | 2016 |
| Bayesian modelling and analysis of spatio-temporal neuronal networks F Rigat, M de Gunst, J van Pelt | 56 | 2006 |
| Co-localization of TLR7 agonist and antigen enhances protection in the S.pneumoniae murine infection model OHD Vecchi S, Bufali S, Uno T,Wu T, Arcidiacono L, Filippini S, Rigat F European Journal of Pharmaceutics and Biopharmaceutics 87, 310-317, 2014 | 38 | 2014 |
| Quantification by LC–MSE of outer membrane vesicle proteins of the BexseroŽ vaccine C Tani, M Stella, D Donnarumma, M Biagini, P Parente, A Vadi, ... Vaccine 32 (11), 1273-1279, 2014 | 37 | 2014 |
| Parallel hierarchical sampling: A general-purpose interacting Markov chains Monte Carlo algorithm F Rigat, A Mira Computational Statistics & Data Analysis 56 (6), 1450-1467, 2012 | 27* | 2012 |
| Systemic oxygen extraction during exercise at high altitude DS Martin, A Cobb, P Meale, K Mitchell, M Edsell, MG Mythen, ... British journal of anaesthesia 114 (4), 677-682, 2015 | 25 | 2015 |
| Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women M Fabbrini, F Rigat, G Tuscano, E Chiarot, G Donders, R Devlieger, ... Journal of Infection 76 (5), 449-456, 2018 | 18 | 2018 |
| Strain coverage of a meningococcal multicomponent (4 CMenB) vaccine in Spain R Abad, L Orlandi, F Rigat, G Boccadifuoco, M Comanducci, A Muzzi 18th International Pathogenic Neisseria Conference, 2012 | 15 | 2012 |
| MATS based coverage prediction for the 4CMenB vaccine on Neisseria meningitidis B (MenB) Brazilian invasive strains A Lemos, M Gorla, M Brandileone, L Orlandi, F Rigat, G Boccadifuoco Poster presented at 18th international pathogenic Neisseria conference (IPNC …, 2012 | 14 | 2012 |
| Isoseparation and robustness in finite parameter Bayesian inference JQ Smith, F Rigat University of Warwick. Centre for Research in Statistical Methodology 2007 (22), 2007 | 14* | 2007 |
| Core values for vaccine evaluation JK Timmis, F Rigat, R Rappuoli Vaccine 35, A57-A62, 2017 | 13 | 2017 |
| Semi-parametric dynamic time series modelling with applications to detecting neural dynamics F Rigat, JQ Smith | 10 | 2009 |
| Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With S. aureus Skin and Soft Tissue Infections From Controls F Rigat, E Bartolini, M Dalsass, N Kumar, S Marchi, P Speziale, D Maione, ... Frontiers in Immunology 10, 114, 2019 | 9 | 2019 |
| A hybrid procedure for detecting global treatment effects in multivariate clinical trials: theory and applications to fMRI studies G Minas, F Rigat, TE Nichols, JAD Aston, N Stallard Statistics in medicine 31 (3), 253-268, 2012 | 7 | 2012 |
Rino RappuoliGSK VaccinesVerified email at gsk.com
